Celleron Therapeutics - Publications

Carey N, La Thangue NB.
Histone deacetylase inhibitors: gathering pace Current Opinion in Pharmacology 2006, 6:369–375
Please click here for the article

Inche AG, La Thangue NB.
Chromatin control and cancer-drug discovery: realizing the promise Drug Discovery Today 2006, Volume 11: No. 3/4
Please click here for the review

Mulholland PJ, Ferry DR, Anderson D, Hussain SA, Young AM, Cook JE, Hodgkin E, Seymour LW, Kerr DJ.
Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. Annals of Oncology 2001;12(2):245-248

Ferry, DR; Smith, A; Malkhandi, J; Fyfe, DW; de Takats, PG; Anderson, D; Baker, J; Kerr, DJ.
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clinical Cancer Res 2: 659-668 (1996)

Liu, B; Anderson, D; Ferry, DR; Seymour, LW; de Takats, PG; Kerr, DJ.
Determination of quercetin in human plasma using reverse-phase high-performance liquid chromatography. J Chromatography B, 666: 149-155 (1995)

L. Stimson, N.B. La Thangue, Biomarkers for predicting clinical responses to HDAC inhibitors, Cancer Lett. (2009), doi:10.1016/j.canlet.2009.03.016
Please click here for the article